Ethyl 6-methyl-3-oxo-2,3-dihydropyridazine-4-carboxylate

Catalog No. :
ACIJAG025
CAS No. :
2125-90-8
Molecular Formula :
C8H10N2O3
Molecular Weight :
182.18

IUPAC Name:ethyl 6-methyl-3-oxo-2,3-dihydropyridazine-4-carboxylate

Ethyl 6-methyl-3-oxo-2,3-dihydropyridazine-4-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$112.00Login to see priceIn stockInquiry
250mg95%$188.00Login to see priceIn stockInquiry
1g95%$427.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 6-methyl-3-oxo-2,3-dihydropyridazine-4-carboxylate
IUPAC Nameethyl 6-methyl-3-oxo-2,3-dihydropyridazine-4-carboxylate
MDL No.MFCD11505026
Molecular FormulaC8H10N2O3
Molecular Weight182.18
SMILESO=C(C1=CC(C)=NNC1=O)OCC
InChI KeyHSFDJZRPWZNKDX-UHFFFAOYSA-N
SynonymEthyl 6-Methyl-3-oxo-2,3-dihydropyridazine-4-carboxylate;2,3-Dihydro-6-methyl-3-oxo-4-pyridazinecarboxylic acid ethyl ester;6-Methyl-3-oxo-2,3-dihydro-pyridazine-4-carboxylic acid ethyl ester;4-Pyridazinecarboxylic acid, 2,3-dihydro-6-methyl-3-oxo-, ethyl ester
CAS No.2125-90-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACIJAG025 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIJAG025 route product structure diagram
    ACIJAG0252125-90-8 In Stock
Inquiry

2. ACIJAG025 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACLBXS039 route compound structure diagram
    ACLBXS03974557-73-6 In Stock
  4. Then
  5. ACIJAG025 route product structure diagram
    ACIJAG0252125-90-8 In Stock
Inquiry

Comments (0)